4-Substituted-kynurenic acid derivatives: A novel class of NMDA receptor glycine site antagonists

1997 ◽  
Vol 20 (4) ◽  
pp. 351-357
Author(s):  
Ran Hee Kim ◽  
Yong Jun Chung ◽  
Chang Woo Lee ◽  
Jae Yang Kong ◽  
Young Sik Jung ◽  
...  
2010 ◽  
Vol 3 ◽  
pp. IJTR.S4260 ◽  
Author(s):  
Klas Linderholm ◽  
Susan Powell ◽  
Elin Olsson ◽  
Maria Holtze ◽  
Ralph Snodgrass ◽  
...  

Kynurenic acid (KYNA) is an endogenous metabolite of tryptophan. Studies have revealed increased brain KYNA levels in patients with schizophrenia. Prepulse inhibition (PPI) is a behavioral model for sensorimotor gating and found to be reduced in schizophrenia. Previous studies have shown that pharmacologically elevated brain KYNA levels disrupt PPI in the rat. The aim of the present study was to investigate the receptor(s) involved in this effect. Rats were treated with different drugs selectively blocking each of the sites that KYNA antagonizes, namely the glutamate recognition site of the N-methyl-D-aspartate receptor (NMDAR), the α7* nicotinic acetylcholine receptor (α7nAChR) and the glycine site of the NMDAR. Kynurenine (200 mg/kg) was given to replicate the effects of increased levels of KYNA on PPI. In order to block the glutamate recognition site of the NMDAR, CGS 19755 (10 mg/kg) or SDZ 220–581 (2.5 mg/kg) were administered and to antagonize the α7nAChR methyllycaconitine (MLA; 6 mg/kg) was given. L-701,324 (1 and 4 mg/kg) or 4-Chloro-kynurenine (4-Cl-KYN; 25, 50 and 100 mg/kg), a drug in situ converted to 7-Chloro-kynurenic acid, were used to block the glycine-site of the NMDAR. Administration of SDZ 220-581 or CGS 19755 was associated with a robust reduction in PPI, whereas L-701,324, 4-Cl-KYN or MLA failed to alter PPI. Kynurenine increased brain KYNA levels 5-fold and tended to decrease PPI. The present study suggests that neither antagonism of the glycine-site of the NMDA receptor nor antagonism of the α7nAChR disrupts PPI, rather with regard to the effects of KYNA, blockade of the glutamate recognition-site is necessary to reduce PPI.


2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Xin Zhang ◽  
Bin Cheng ◽  
Xianghong Jing ◽  
Yongfa Qiao ◽  
Xinyan Gao ◽  
...  

A large number of studies have been conducted to explore the efficacy of electroacupuncture (EA) for the treatment of gastrointestinal motility. While several lines of evidence addressed the basic mechanism of EA on gastrointestinal motility regarding effects of limb and abdomen points, the mechanism for effects of the back points on gastric motility still remains unclear. Here we report that the NMDA receptor (NMDAR) antagonist kynurenic acid inhibited the gastric emptying increase induced by high-intensity EA at BL21 and agonist NMDA enhanced the effect of the same treatment. EA at BL21 enhanced NMDAR, but not AMPA receptor (AMPAR) component of miniature excitatory postsynaptic current (mEPSC) in gastric-projecting neurons of the dorsal motor nucleus of the vagus (DMV). In sum, our data demonstrate an important role of NMDAR-mediated synaptic transmission of gastric-projecting DMV neurons in mediating EA at BL21-induced enhancement of gastric emptying.


Pain ◽  
2003 ◽  
Author(s):  
C Carignani ◽  
M Mugnaini ◽  
E Ratti ◽  
M Corsi ◽  
G Dal Forno ◽  
...  
Keyword(s):  

1992 ◽  
Vol 2 (5) ◽  
pp. 371-374 ◽  
Author(s):  
Graeme I. Stevenson ◽  
Paul D. Leeson ◽  
Michael Rowley ◽  
Ian Sanderson ◽  
Ian Stansfield

1995 ◽  
Vol 5 (18) ◽  
pp. 2089-2092 ◽  
Author(s):  
Michael Rowley ◽  
Paul Leeson ◽  
Sarah Grimwood ◽  
George Marshall ◽  
Kay Saywell
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document